StonvexLoading…
StonvexStonvexStonvexCore line items from HCA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2021 2021-09-30 | Q2 2021 2021-06-30 | Q1 2021 2021-03-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $43.69B | $28.41B | $13.98B | $51.53B |
Operating Income | $7.25B | $4.09B | $1.97B | $5.43B |
Net Income | $5.14B | $2.87B | $1.42B | $3.75B |
EPS (Diluted) | $15.43 | $8.50 | $4.14 | $10.93 |
Total Assets | $49.56B | $48.16B | $47.28B | $47.49B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.03B | $1.12B | $1.03B | $1.79B |
Free Cash Flow OCF − CapEx | $4.13B | $2.74B | $1.33B | $6.40B |
Shares Outstanding | 313.50M | 322.82M | 333.71M | 339.43M |